22:04

CALQUENCE® (acalabrutinib) ELEVATE-TN, Including 6-Year Median Follow-Up Data – Dr O’ Brien, MD

17:23

CALQUENCE® (acalabrutinib) Pooled Safety Analysis – Dr Pinilla-lbarz, MD

1:08:05

A Patient Story

15:59

CALQUENCE® (acalabrutinib) Long-Term Data – Dr Brem, MD

27:13

Dr Daniel Landau Presents CALQUENCE Long-Term and Pooled Cardiovascular Safety Data for CLL/SLL

16:42

CALQUENCE® (acalabrutinib) Patient Management & Adherence – Bradley, NP

19:00

CALQUENCE® (acalabrutinib) ELEVATE-RR and ASCEND Data – Dr Ma, MD

8:23

Sharon's Treatment Story